BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2018
View Archived Issues
Crinetics Pharmaceuticals awarded NIDDK grants
Read More
iTeos Therapeutics completes series B financing to support immuno-oncology programs
Read More
Biocad initiates phase I study of BCD-132 in patients with multiple sclerosis
Read More
First-in-human data presented for oncolytic virus Celyvir in solid tumors
Read More
Lilly's acquisition of ARMO BioSciences complete
Read More
Phase I results available for CUDC-907 in pediatric solid tumors
Read More
ARQ-531 demonstrates preliminary signs of antitumor activity in B-cell malignancies
Read More
AZD-9567 shows better therapeutic ratio than prednisolone in vivo and in clinical setting
Read More
FDA awards orphan drug designation to PCS-499 for necrobiosis lipoidica
Read More
Ohara Pharmaceutical obtains certain rights to compound from PRISM Pharma
Read More
City of Hope studies memory-enriched T cells in recurrent or refractory glioma
Read More
IMpower133 study of Tecentriq in extensive stage SCLC meets coprimary endpoints
Read More
Erytech refocuses development efforts with eryaspase
Read More
YH-25448 demonstrates promising antitumor activity in patients with EGFR T790M-positive NSCLC
Read More
Prefusion F protein respiratory syncytial virus vaccine DS-Cav1 safe in first-in-human study
Read More
FDA clears IND for pivotal trial of INP-104 for acute treatment of migraine
Read More
J-TEC signs license agreement for low-cost manufacturing technology of CAR-T cells
Read More
Cellenkos and University of Texas enter neuroinflammation research collaboration
Read More
DSMB of Aladote phase Ib/IIa study to treat paracetamol poisoning finds no safety concerns
Read More
Merrimack discontinues development of MM-141 for pancreatic cancer following CARRIE results
Read More
CellCentric initiates first-in-man study of CCS-1477 for late-stage prostate cancer
Read More